Ziv-aflibercept, CAS 1609655-49-3

Product Description: Ziv-aflibercept is a soluble inhibitor of vascular endothelial growth factor (VEGF). Ziv-aflibercept is an adaptive variant of Aflibercept (HY-108801), Ziv-aflibercept has a low PH value and high osmotic pressure when compared to Aflibercept. Ziv-aflibercept has potential applications in metastatic colorectal carcinoma and retinal diseases[1][2].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Malik D, et al. Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture. Br J Ophthalmol. 2014 Jun;98 Suppl 1(Suppl 1):i11-16. /[2]de Oliveira Dias JR, et al. Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept. Int J Retina Vitreous. 2016 Feb 1;2:3.

CAS Number: 1609655-49-3

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Cancer; Cardiovascular Disease

Solubility: 10 mM in DMSO

Target: VEGFR

• Artikelnummer: MEXHY-108798-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-108798-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK